Introduction
One of the critical events in the pathogenesis of atherosclerotic lesions is the focal accumulation of lipid-laden foam cells beneath an intact arterial endothelial lining (1) (2) (3) . In various cholesterol-fed animal models of atherosclerosis, localized attachment of circulating monocytes to arterial endothelium appears to precede the formation ofearly foam cell lesions (1) (2) (3) (4) (5) (6) .. Although the molecular mechanisms are not completely understood, monocyte recruitment into these early lesions may involve changes in endothelial adhesiveness for monocytes, and local generation of soluble vessel wall-derived monocyte chemoattractants (7) (8) (9) . In vitro studies have identified three molecules, intercellular adhesion molecule-1 (ICAM- 1 [CD54 1) ( 10, 11 ), E-selectin (endothelial-leukocyte adhesion molecule-1 [ ELAM-1]) ( 12, 13) , and vascular cell adhesion molecule-1 (VCAM-1) (14) , that are inducible on the endothelial surface and can support the adhesion of various leukocytes, including monocytes ( 15, 16) . Our laboratory has recently demonstrated that VCAM-1 is inducible in activated rabbit aortic endothelial cells in culture, and also is focally expressed in vivo in arterial endothelium overlying early foam cell lesions in both dietary and genetic models of atherosclerosis in the rabbit (17) . Immunohistochemical examination of aortas from cholesterol-fed rabbits indicates that VCAM-1 can be detected in arterial endothelium before the accumulation of intimal macrophages, suggesting that this molecule may play a role in the recruitment of blood monocytes into early lesions ( 18 ) . Recent studies by others have shown that ICAM-1 also is expressed in human atherosclerotic lesions in vivo ( 19) . However, the stimuli present in developing atherosclerotic lesions that might be responsible for focal up-regulation of VCAM-1, ICAM-1, and other potentially relevant leukocyte adhesion molecules have not been defined.
Several lines of evidence have indicated that oxidatively modified low density lipoproteins (LDL) play a key role in atherogenesis (3, (20) (21) (22) (23) . In cholesterol-fed rabbit models of atherosclerosis, the major increased lipoprotein fraction is 3-VLDL (3). One of the characteristic features of both oxidized LDL and f-VLDL particles is their dramatically increased content of lysophosphatidylcholine (lyso-PC) (3, 20, (24) (25) (26) (27) . Lyso-PC has been demonstrated to be a selective chemoattractant for mononuclear leukocytes (24) , and appears to be the component of oxidized LDL responsible for its inhibitory effect on endothelial-dependent vasodilation (25, 26) . Furthermore, the concentration of lyso-PC is increased in atherosclerotic arterial lesions in animals fed an atherosclerotic diet (28 Cells. Rabbit aortic endothelial cells were isolated by collagenase digestion from thoracic aortas from male New Zealand White rabbits (Pasturella-free, 3-4 kg, Millbrook Farms, Amherst, MA), seeded in plastic plates (Costar, Cambridge, MA) precoated with 0.1% gelatin (Difco Laboratories, Detroit, MI) and cultured in Medium 199 supplemented with 20% fetal bovine serum (FBS), 12.5 jig/ml endothelial cell growth supplement, 25 U/ml heparin, 100 U/ml penicillin, and 100 Mg/ml streptomycin ( 17 ) . Human umbilical vein endothelial cells were isolated and cultured as previously described (29 ( 17) . Specific cell surface binding in this assay was calculated by subtracting the fluorescence detected in monolayers incubated with a class-matched nonbinding primary mAb. A stimulation index for immunobinding was calculated as the ratio of specific cell surface mAb binding to monolayers treated with lyso-PC or other test stimuli, versus monolayers treated with medium alone.
Northern blot analysis. Total cellular RNA extracted from cultured rabbit aortic or human umbilical vein endothelial cells by acid-guanidinium phenol-chloroform method (32) was electrophoresed through 1% agarose gels containing formaldehyde, and transferred to nitrocellulose membranes (Schleicher & Schuell, Inc., Keene, NH). Northern blots were hybridized with rabbit VCAM-I or human ICAM-l cDNA probes labeled by [a-32P]dCTP (Amersham Corp., Arlington Heights, IL) using random hexanucleotide primers (Pharmacia, Inc., Piscataway, NJ) (33). A 2.1-kb Hind III/Pst I fragment of rabbit VCAM-1 cDNA or a 1.3-kb Xho I fragment of human ICAM-1 cDNA was utilized. The ICAM-I cDNA was provided by Dr. Brian Seed (Massachusetts General Hospital, Boston, MA) ( 10). The blots were rehybridized with radiolabeled rat brain a-tubulin cDNA.
Leukocvte adhesion assays. Leukocyte adhesion assays were performed in microtiter plates as previously described ( 17, 29) . After incubated with test stimuli or media alone, endothelial monolayers were washed three times with RPMI 1640 1% FBS. BCECF-labeled leukocytes (2 x 105 cells in 200 ,l of RPMI 1640 1% FBS/32-mm2 well) were added, and microtiter plates were incubated for 10 min at 37°C. The plates were sealed, inverted, and centrifuged (250 g) for 5 min to separate nonadherent leukocytes. Adherent cells were lysed with 50 mM Tris, pH 8.4, 0.1% SDS, and their fluorescence was measured. A stimulation index for leukocyte adhesion was calculated as the ratio of the number of leukocytes associated with lyso-PC-or LPS-treated versus sham-treated endothelial monolayers.
Statistical analysis. The statistical significance of the differences among means of groups was determined using Student's two-sample t test or analysis of variance.
Results
Lyso-PC tup-regulates expression of VCAM-1 and ICAM-I in rabbit aortic endothelial cells. Cultured rabbit aortic endothelial cell monolayers were treated with lyso-PC in Medium 199 containing 5% FBS, and cell surface expression of VCAM-1 was measured by fluorescence immunobinding assays using Rbl /9, a mAb specific for rabbit VCAM-1. Lyso-PC treatment up-regulated the cell surface expression of VCAM-1 in a doseand time-dependent fashion. In response to 100 ,uM lyso-PC, VCAM-1 was significantly induced above baseline at 4 h, and continued to increase in a sustained fashion for at least 36 h (Fig. 1 A) . Concentrations of lyso-PC as low as 50 ,uM suspended in 5% FBS caused a significant increase in VCAM-1 expression detected at 24 h of treatment, with a maximal effect observed at 100,uM (Fig. 1 B) . As seen in Table I , after 24 h of treatment, the extent of VCAM-1 induction by lyso-PC was variable among experiments (3-24-fold increases); however, in a given experiment, the stimulation obtained with lyso-PC was comparable (60-146%) to that obtained with a maximally effective concentration of Gram-negative bacterial endotoxin (LPS, 1 Ag/ml). Cell surface expression of ICAM-1, as detected by mAb Rb2 / 3, also was increased by lyso-PC treatment by 1.4-6.2-fold (38-108% of maximal LPS stimulation). In contrast, a constitutively expressed antigen on the surface of rabbit endothelium recognized by mAb Rb2/13 (IgG,) was not significantly affected by lyso-PC treatment (Table I) .
Northern blot analysis demonstrated that increased cell surface expression of VCAM-1 on rabbit aortic endothelium was correlated with a significant increase in VCAM-1 mRNA (Fig. 2) . Two predominant species of rabbit VCAM-1 mRNA were found, consistent with alternative mRNA splicing (34) or differential polyadenylation.
Lyso-PC pretreatment of rabbit aortic endothelial cells increases adhesion of blood monocytes and monocyte-like cell lines. To determine if increased cell surface expression of leukocyte adhesion molecules induced by lyso-PC correlated with a hyperadhesive endothelial phenotype, leukocyte adhesion assays were performed with human monocyte-like cell lines, THP-1 and U937. Lyso-PC pretreatment ofrabbit aortic endothelial monolayers resulted in increased adhesion of each of these leukocytes, 1.6-3.5-fold for THP-1 cells, and 1.4-2.0-fold for U937 cells (Table II) . Adhesion ofelutriated human blood monocytes to lyso-PC-treated rabbit aortic endothelial cells also was enhanced by 1.4-fold (P < 0.01, one experiment) under similar assay conditions. Addition of lyso-PC immediately preceding the leukocyte adhesion assay, followed by the standard washing procedure, did not increase monocyte adhesion (data not shown).
Lyso-PC differentially induces ELAM in human arterial and venous endothelial cells. We further characterized the effect of lyso-PC on cultured human endothelial cells. We found that lyso-PC induced cell surface expression of both VCAM-I and ICAM-1 in human iliac arterial cells, in a comparable fash- ion to that observed with rabbit aortic endothelial cells (Fig. 3) . In contrast, in human umbilical vein endothelial cells, lyso-PC only induced ICAM-1 expression (Fig. 3) . This up-regulation of ICAM-1 was much slower than that elicited by IL-1 (Fig. 4) , and appeared similar to the pattern of VCAM-1 induction by lyso-PC observed in rabbit aortic endothelial cells, as shown in Fig. 1 Effects of other polar phospholipids on the induction of VCAM-I and ICAM-J. Lyso-PC is a polar phospholipid which can exhibit detergent-like properties. Generally, in an aqueous solution, such amphiphiles can cause cell lysis above their critical micellar concentrations. Previous studies have shown that critical micellar concentration of lyso-PC (C 16:0) is 40-50 ,uM in protein-free physiological salt solutions (35) . In fact, we observed that 50 ,uM or higher concentrations of lyso-PC in serum-free culture media caused morphologically apparent endothelial cell damage within a few hours. Because lyso-PC avidly binds to proteins such as albumin, we included 5% FBS in the culture media and thereby increased its actual critical micellar concentration. With this incubation medium, we did not detect any cytotoxicity, as evidenced by phase-contrast microscopy or lactate dehydrogenase release, at lyso-PC concentrations up to 100 ,uM. The effects of other lysophospholipids structurally similar to lyso-PC were examined, although such lysophospholipids typically are far less abundant in the body. As shown in Table  III , when tested on both VCAM-1 induction in rabbit aortic endothelial cells and ICAM-1 induction in human umbilical vein endothelial cells at comparable concentrations, lysophosphatidylethanolamine was as effective as lyso-PC, while lysophosphatidylinositol and lysophosphatidylserine appeared less effective, and phosphatidylcholine was not active. The structural specificity of lyso-PC effect was further characterized in human umbilical vein endothelial cells, using hydrolyzable and nonhydrolyzable analogues of lyso-PC (36) . As seen in Table IV , l-palmityl-propanediol-3-phosphocholine, a nonhydrolyzable analogue, did not up-regulate ICAM-1 and actually caused cytotoxicity. In contrast, 1-palmitoyl-ethanediol-2-phosphocholine, a hydrolyzable analogue, induced ICAM-1 expression in a dose-dependent fashion without evidence of cytotoxicity. Taken together, these observations suggest that the induction of endothelial-leukocyte adhesion molecules by lyso-PC or other lysophospholipids is separable from their detergent-like actions and may depend upon their active metabolism by endothelial cells.
Discussion
Adhesion of blood monocytes to the arterial endothelial surface, preceding their subsequent transmigration into the intima, is one of the key steps in atherogenesis ( 1-6). Once present within the developing lesion, monocyte/macrophages (as well as lymphocytes that also accumulate) have the capacity to produce various cytokines which, in turn, can activate endothelial cells locally to express adhesion molecules. Although such potential paracrine mechanisms for amplifying leukocyte recruitment are becoming better defined (37), the stimuli responsible for the initial monocyte recruitment into the arterial intima have not yet been identified. One of the earliest changes during atherogenesis, in cholesterol-fed animal models, is the focal accumulation of LDL in regions of the arterial wall, which subsequently develop foam cell lesions (38) Time (hours) modification of LDL can occur in arterial intima and may play a crucial role in atherogenesis (3, (20) (21) (22) (23) . Therefore, it is reasonable to hypothesize that oxidatively modified LDL, or one of its components, might be a initial stimulus for monocyte recruitment in this disease setting. Recent in vitro studies have shown that cultured endothelial cells incubated with minimally oxidized LDL or 3-VLDL exhibit enhanced adhesiveness for monocytes (39, 40) as well as the production of monocyte chemoattractant (9); however, neither component(s) of these lipoproteins responsible for these effects, nor their molecular mechanisms, have been fully clarified. As an initial approach to this problem, we isolated human plasma LDL and subjected it to various degrees ofcontrolled oxidation, using cupric (41 ) or ferrous ions (39) in vitro, and then examined whether these modified lipoprotein preparations could activate cultured endothelial cells to enhance monocyte adhesion mechanisms. None of these oxidized LDL preparations (which contained 1-10 nmol malon- (42), the biological properties of oxidized LDL might vary among laboratories and different preparations, in that thiobarbituric acid-reactive substance, which is the usual measure of the extent of oxidative modification of LDL, does not adequately reflect all the relevant features of the modified lipoprotein particle. We, therefore, considered the possibility that something associated with oxidized LDL preparations might be involved. As we demonstrate here, lyso-PC, a polar phospholipid that is increased in oxidized LDL (3, 20, 24, 26, 27) can up-regulate the expression ofendothelial-leukocyte ad- The potential molecular mechanisms of endothelial activation by polar phospholipids such as lyso-PC appear to be multiple and complex. Taken together, our results with hydrolyzable and nonhydrolyzable analogues oflyso-PC suggest that specific molecular transformations rather than non-specific (e.g., detergent-like) actions are involved. Previous studies with human monocytes (36) and a lymphoblastic cell line (43) have implicated the generation ofdiacylglycerol, via a metabolic pathway involving (lyso)phospholipase C, in the chemotactic action of exogenous lyso-PC. Diacylglycerol, an important intracellular second messenger and activator ofprotein kinase C (44), could conceivably also be generated from lyso-PC in endothelial cells through the sequential action of a phosphatidylcholine-hydrolyzing phospholipase D activity and phosphatidate phosphatase. Both protein kinase C-dependent and -independent mechanisms have been described in the induction of adhesion molecules (E-selectin, ICAM-1, and VCAM-1) by the inflammatory cytokine TNF, in vascular endothelial cells (45) (46) (47) . Our preliminary studies with the protein kinase C inhibitor, staurosporine, failed to show any consistent inhibition of lyso-PC-induced ICAM-1 expression in human umbilical vein endothelial cells. Given the striking differences in the pattern of endothelial adhesion molecule induction by lyso-PC compared with well-characterized activators such as IL-1, TNF, and LPS, further studies of VCAM-1 and ICAM-1 induction by lyso-PC might be expected to provide new information regarding the molecular mechanisms of endothelial activation.
The present study demonstrates that lyso-PC can activate endothelial cells to differentially express certain adhesion molecules in vitro, and suggests that this naturally occurring phospholipid may be an important stimulus for mononuclear leukocyte recruitment into the arterial intima during atherogenesis, in vivo. In this respect, it may function either alone or in combination with inflammatory cytokines generated locally by activated vessel wall cells and emigrating leukocytes (37) . Interestingly, preliminary data have recently been presented that lyso-PC also can act on monocyte/ macrophages to up-regulate growth factor gene expression (48) , thus further illustrating its potential role in atherogenesis. In addition to its presence in atherogenic lipoproteins, such as oxidatively modified LDL and f-VLDL, biologically significant amounts of lyso-PC can also be generated via the action ofphospholipase A2 secreted by leukocytes, platelets, and other cells in inflammatory tissues (49). Thus, lyso-PC may contribute to acute and chronic inflammation through both its previously described direct chemoattractant actions (24) and the up-regulation of relevant endothelial adhesion mechanisms. Interventions which prevent the conversion of phosphatidylcholine into lyso-PC in vivo would be predicted to act to reduce the recruitment of mononuclear leukocytes in various pathophysiologic settings. Further studies of the mechanisms responsible for the local generation and cellular actions of lyso-PC may provide fresh insights into the atherosclerotic disease process.
